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Background: Although hopelessness has been studied in cancer, no data are available in non-
English-speaking countries. Objective: The authors sought to amass data from Southern Euro-
pean countries (Italy, Portugal, Spain, and Switzerland) in order to ﬁll this void. Method: A
group of 312 cancer patients completed the Mini-MAC Hopelessness subscale, the Hospital Anx-
iety and Depression Scale (HADS), the Cancer Worry Inventory (CWI), and a six-item Visual
Analog scale (VAS) to measure intensity of physical symptoms, general well-being, difﬁculty in
coping with cancer, intensity of social support from close relationships, leisure activity, and sup-
port from religious beliefs. Results: Regression analysis indicated that HADS–Depression, VAS
Maladaptive Coping and Well-Being, and the CWI explained 42% of the variance. Conclusion:
Hopelessness in cancer patients seems not exclusively to correspond to depression, but is related
to various other psychosocial factors, such as maladaptive coping, as well.
(Psychosomatics 2010; 51:201–207)
Hopelessness, as a subjective and affective state char-acterized by a negative view of the future, a sense of
loss of control, conﬁdence, courage, and the energy to
achieve one’s own goals, has been extensively studied
over the last 20 years.1–3 Symptoms of hopelessness, as a
speciﬁc cluster within affective disorders,4 have been
shown to correlate more with each other than with other
depressive symptoms and more than with other psychopa-
thology symptoms.5 Hopelessness has also been reported
not only as being present in depressive disorders, but to be
the major indicator of demoralization, independent of the
presence of clinical depression.6
Hopelessness is also one of the most frequent and
important conditions described in medically ill patients.7
The feeling that hopes have been destroyed or that a di-
lemma cannot be resolved makes hopelessness common in
cancer patients. Hopelessness can threaten a patient’s
physical and psychological well-being and can affect the
process of recovery and rehabilitation. Likewise, hopeless-
ness has been found to be present among medically ill
patients who meet the criteria for demoralization (i.e., the
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feeling of having failed to meet one’s own expectations or
those of other people; feeling unable to cope with a current
urgent problem; feelings of helplessness, hopelessness,
and/ or giving up), according to the Diagnostic Criteria for
Psychosomatic Research (DCPR),8 rather than major de-
pression, according to the DSM–IV.9
In oncology, a number of studies have focused on
hopelessness as a maladaptive coping style. Hopelessness
has been associated with poor adjustment to illness; this
includes depression,10,11 low satisfaction with support re-
ceived from interpersonal ties,12 and poor quality of life.13
Hopelessness also contributed uniquely to the prediction
of suicidal ideation, controlling for level of depression,
among cancer patients in an advanced phase of illness.14
Furthermore, hopelessness and depression mediated the
pathways between illness-related factors and desire for
hastened death both in hospitalized15 and terminally-ill
cancer patients.16,17 Research also seem to suggest the
possibility of a connection between hopelessness and can-
cer prognosis. In a 10-year follow-up investigation of 450
breast cancer patients, hopelessness, rather than depres-
sion, was shown to predict both recurrence of illness and
reduced survival time.18 Hopelessness has been shown to
be a strong predictor of both incidence of and death from
cancer, independent of depression and traditional biolog-
ical risk factors in general-population studies.19,20
No study has explored the concept of hopelessness in
non-English–speaking countries. However, cultural issues
have been indicated as important variables to be taken into
account when examining emotional states and coping with
cancer.21 Differences between Portuguese and American
cancer patients have been described in terms of quality of
life and social lifestyle.22 Satisfaction with medical care
among French, Italian, Polish, and Swedish cancer patients
has also been considered in relation to their respective
cultural backgrounds.23 Fatalism was found to be more
prevalent among Portuguese than Italian patients.24
With this background in mind, the aims of the present
study were to examine the relationship between hopeless-
ness and depression in high-functioning cancer patients
with mildly-to-moderately advanced disease and to eval-
uate the role of other medical, psychosocial, and cultural
factors in inﬂuencing hopelessness.
METHOD
Subjects
The study was carried out in university hospitals and
afﬁliated cancer centers in Southern European countries
(Italy, Portugal, Spain, and Switzerland), as part of a larger
research and educational investigation involving Mediter-
ranean countries (the Southern European Psycho-Oncol-
ogy Study–SEPOS).24–27 As described elsewhere,24 a con-
venience sample of cancer patients was enrolled in the
outpatient and day-hospital services of the participating
centers. The selection criteria were the following: patients
were age 18–70 years; had had a diagnosis of cancer for
between 6 and 18 months; had no cognitive impairment
due to the disease or side effects of treatment, as evaluated
both at the clinical level (orientation to time, space, and
person; short-term memory) and through the Mini-Mental
State Exam (cutoff: 24).28 Furthermore, since the original
study also had the aim of evaluating the ability of physi-
cians to assess their patients’ psychosocial morbidity, only
patients reporting a score 80 on the Karnofsky Perfor-
mance Status Scale (KPSS)29 were selected, in order to
avoid the possibility of patients’ poor physical condition
negatively inﬂuencing the doctors’ ability to assess psy-
chosocial disorders, which are more complex to evaluate
in the advanced stages of illness.30 The study was ap-
proved by the ethical committees of the respective hospi-
tals. Each patient received detailed information of the aim
of the study and gave his or her written consent for par-
ticipation.
Procedures
Each patient was individually interviewed by research
psychologists administering an abbreviated semistructured
interview developed for the study and evaluated in pre-
research meetings. The ﬁrst part of the interview collected
information about previous psychiatric disorders before
the diagnosis of cancer (lifetime history of psychopathol-
ogy). On the basis of previous literature concerning the
relationship between stress and depression in cancer pa-
tients,31 the second part of the interview investigated life
events in the last 5 years.
A booklet with self-report psychometric instruments
was then given to the patients. Hopelessness was measured
with the Hopelessness factor of the Mini-Mental Adjust-
ment to Cancer scale (Mini-MAC).32 The Mini-MAC and
its more complete version, the MAC, are among the few
scales that examine patients’ cognitive and behavioral at-
titudes toward cancer. The Mini-MAC Hopelessness fac-
tor is an eight-item subscale on a 1–4 Likert scale (1: It
deﬁnitely does not apply to me, to 4: It applies to me; score
range: 8–32; Table 1), measuring the tendency to adopt a
pessimistic and despairing attitude about the illness.
SEPOS: Hopelessness and Cancer
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A series of other self-report instruments was also
given to the patients in order to examine their association
with hopelessness: the Hospital Anxiety and Depression
Scale (HADS), the Cancer Worries Inventory (CWI), and
the six-item, 0–10 per-item Visual Analog Scale (VAS).
The HADS33 is a widely used questionnaire consist-
ing of 14 items, which have been speciﬁcally developed to
be applied in medical settings. It has been repeatedly used
in oncology to assess anxiety (7 items) and depression (7
items), on a 0–3 Likert-scale (score range: 0–21), with
several studies indicating the usefulness, reliability, and
validity of the HADS in cancer settings.34 Recommenda-
tion on the use of cutoff score 11 to identify “clinical
cases” of depression33 on the Anxiety subscale was also
taken into account, with the hypothesis that hopelessness
could be related to anxiety, along with depression.
The CWI35 is a 15-item questionnaire examining, on
a 1–4 Likert scale, several possible concerns, including
physical problems (e.g., the effects of surgery, the effects
of chemotherapy, physical symptoms), emotional prob-
lems (e.g., emotional symptoms, feeling different from
others; concerns about the future), relationship worries
(e.g., being a burden to the family; worries with respect to
sexual life and the relationship with one’s own partner),
and economic worries (e.g., work-related issues, including
housework; not being able to carry out one’s daily activ-
ities). Cronbach  reliability of the CWI was good
(0.88).
Last, given that the use of the VAS to measure single
dimensions in cancer such as distress, mood, fatigue, and
physical symptoms has been reported in the literature,36,37
patients also completed a six-item VAS, with the instruc-
tions: “Please read each situation concerning your illness
and make a cross along the line in the place that best
applies to you and to how you felt during the last 2
weeks.” Patients were asked to rate, on a scale of 0–10, the
intensity of each single items (from 0: no problem/not at
all; to 10: extreme problems/extreme), namely: “The in-
tensity of my physical symptoms,” “My general well-
being,” “The difﬁculty I have in coping with cancer,” “The
support (emotional and/or practical) I receive from close
persons,” “My leisure activity,” and “The support I have
from my faith in giving meaning to my existence.”
Statistical Analysis
Statistical analysis was performed with the SPSS 10.4
package. Distribution and frequency analyses were used to
TABLE 1. Items of the Mini-MAC (Mental Adjustment to Cancer) Hopelessness Subscale and Interquartile Ranges
Items Mean (SD) Median Interquartile Range
I feel like giving up. 1.45 (0.81) 1 25–1
50–1
75–2
I feel completely at a loss about what to do. 1.53 (0.78) 1 25–1
50–1
75–2
I can’t handle it. 1.69 (0.89) 1 25–1
50–1
75–2
I am not very hopeful about the future. 1.81 (0.96) 2 25–1
50–2
75–2
I feel there is nothing I can do to help myself. 1.61 (0.82) 1 25–1
50–1
75–2
I think it is the end of the world. 1.63 (0.89) 1 25–1
50–1
75–2
I feel that life is hopeless. 1.52 (0.79) 1 25–1
50–1
75–2
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evaluate the samples. Correlational analysis was per-
formed with Pearson’s r coefﬁcient test. Student’s t-test,
ANOVA (F), and chi-square tests (2) were used to ex-
amine inter- and intra-samples differences. Univariate and
two-way analysis of variance (ANOVA), multiple regres-
sion analysis, and ANCOVA were used when appropriate.
Statistical signiﬁcance was set at the 0.05 level.
RESULTS
A total of 313 patients were selected from the centers
participating in the study (Italian-speaking area [Ferrara
and Lugano, Italy]: N155; Portuguese-speaking area
[Lisbon, Portugal]: N90; Spanish-speaking area [Barce-
lona, Spain]: N68). Complete data on all measures were
available for 312 patients. Most patients were women
(N218; 68.9%); one-third (N94; 29.1%) were men.
The mean age was 56.7 years (standard deviation [SD]:
13.14). Sociodemographic and clinical data are presented
in Table 2.
The Hopelessness measure showed acceptable levels
of reliability in this study (Cronbach : 0.77). According
to the HADS’ identiﬁcation of “caseness” of depression,
Hopelessness scores were higher among “cases” (N28;
8.7%) than among patients with depression scores in the
normal range (N236; 73.1%; 20.79 [6.75] versus 11.77
[4.28]; F [2]46.8; p0.001).
Patients with previous psychiatric episodes (N55;
17.6%) had Hopelessness scores similar to those with no
previous episodes (12.65 [4.33] versus 12.88 [5.25];
t034; NS). Likewise, patients reporting stressful events
in the previous year (N184; 59%) did not differ on
Hopelessness scores from those not reporting such life
events (12.76 [4.98] versus 13.11 [5.38], t0.59; NS).
No differences were found by stage of cancer (F
[2]1.38; NS) or type of treatment (chemotherapy, hor-
mone-therapy, radiotherapy, no therapy; F [3]1.4; NS).
Patients with breast cancer (N150) reported marginally
lower Hopelessness scores than patients with other types
of cancer (N162; 12.3 [4.64] versus 13.53 [5.61]; t2.1,
p0.03). There was also no difference in Hopelessness
among centers (F [4]2.12; p0.07). Univariate ANOVA
indicated no effect for gender or country on Hopelessness
and no interaction between gender and country.
The Hopelessness mean score (12.72 [4.95]) was
slightly higher than that reported in the English validation
study, involving 565 patients (11.96 [3.91]; t2.5;
p0.013). Hopelessness was marginally associated with
age (r0.13; p0.05), and signiﬁcantly associated with
HADS–Depression (r0.55; p0.001), HADS–Anxiety
(r0.51; p0.001), CWI score (r0.49; p0.01), VAS
General Well-Being (r  –0.48; p0.01), Maladaptive
Coping (r0.46; p0.01), and Leisure Activity (r 
–0.35; p0.01); correlations are shown in Table 3. Al-
though statistically signiﬁcant, lower correlations were
found between Hopelessness and VAS–Symptoms
(r0.15; p0.014) and Support From Others (r  –0.18;
p 0.01).
Regression Analysis
We then performed multiple-regression analyses on
these psychological variables (i.e., HADS–Depression,
HADS–Anxiety, Total CWI score, and 6-item VAS),
which were regressed on the Hopelessness variable.
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Other 13 (4.16%)
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HADS–Depression entered the equation accounting for
30% of the explained variance, followed by CWI–Total,
which accounted for an additional 8%, VAS–Maladaptive
Coping (2%), VAS–Well-Being (1%), and VAS–Symp-
toms (1%), respectively. Together, all of these factors
explained 42% of the total variance (F44.24; p0.001).
A different model was used by excluding HADS–Depres-
sion and keeping all the other factors. CWI–Total
explained 28% of the variance, followed by VAS–Mal-
adaptive Coping (7%), VAS–Well-Being (4%), and VAS–
Symptoms (1%), respectively (total variance explained:
39%).
In order to check for other possible differences,
ANCOVA was also performed, with country-of-origin and
gender included as discrete variables, and predictors previ-
ously included in the model were included as continuous
variables. No statistically signiﬁcant interaction was shown
between the covariate and the predictor variables (Fs ranging
between 0.33 [p0.95] and 1.75 [p0.08]).
DISCUSSION
In this study, we examined the characteristics of hopeless-
ness among Southern European cancer patients. Hopeless-
ness was not exclusively related to depression, as mea-
sured by the HADS–Depression scale. In fact, although
HADS–Depression explained a high proportion of vari-
ance, other factors intervened in the prediction of hope-
lessness in cancer patients. More speciﬁcally, hopeless-
ness was associated with a series of cancer-related worries,
such as feeling different from others, with the conjoint
feelings of alienation, the negative impact of the illness in
the relationship with one’s partner, and the negative ef-
fects of surgery. This is in line with data showing that
speciﬁc worries caused by cancer inﬂuence the patients’
subjective response, such as degree of threat assessed, the
reporting of a response of helplessness, and perceived
difﬁculty in resolving concerns. This, in turn, can favor the
development of affective disorders over time.38
Two other dimensions were predictive of hopeless-
ness—namely, Maladaptive Coping (i.e., not being able to
cope with cancer and its implications) and poor General
Well-Being. Although it is understandable and expected
that difﬁculty in coping with illness could be associated
with hopelessness, as a speciﬁc component of coping dys-
function, it is important to point out that the subjective
perception of poor well-being was also related to hope-
lessness responses. This underscores the need to consider
the patient’s subjective experience of his or her well-being
and functional status in all phases of illness, and not only
in advanced or terminal cancer, where poor well-being is,
in fact, associated with hopelessness, depression, suicidal
ideation, and poor quality of life.14,39
Interestingly, no other psychosocial variables, even
previous psychiatric episodes, stressful events in the last
year, or spiritual beliefs, were related to hopelessness.
Likewise, medical variables, such as stage and site of
cancer or type of treatment, did not appear to inﬂuence
hopelessness, although breast cancer patients reported
lower scores than patients with other types of cancer.
Several limitations of the study should be considered.
First, depression was evaluated with a psychometric in-
strument (the HADS–Depression scale), rather than a
more structured clinical interview. Likewise, the Hope-
lessness subscale of the Mini-MAC has only face-validity,
since no study examined its validity in comparison with
other hopelessness scales in cancer patients. Second, the
small size of the sample and the patients’ high functioning
level also limit the conclusions of the study. On the other
hand, the fact that patients had mildly-to-moderately ad-
vanced disease, reinforces the results that have emerged
from studies examining hopelessness in more-advanced
cancer patients and in palliative care. A third limitation
relates to the impossibility of generalizing the results to
the whole cancer population of the three participating
Southern European countries, even if the sample was rep-
resentative of the centers where the study was carried out.
The heterogeneity of the patient sample in terms of cancer
site, stage, and treatment received, also prevents us from
generalizing the results of the study.
We should also note that items belonging to the Hope-
lessness dimension, as measured by the Mini-MAC, have
many overlaps with the criteria proposed by Kissane
TABLE 3. Correlations Between the Mini-MAC (Mental
Adjustment to Cancer) Hopelessness and
Psychosocial Measures
Psychosocial Measure r p
HADS Depression (HADS–D) 0.55 0.001
Cancer Worry Inventory (CWI) 0.49 0.001
VAS–Physical Symptoms 0.10 NS
VAS–Well-Being –0.48 0.001
VAS–Leisure –0.35 0.01
VAS–Social Support –0.19 0.05
VAS–Maladaptive Coping 0.46 0.001
VAS–Support From Religion –0.08 NS
HADS: Hospital Anxiety and Depression Scale; CWI: Cancer
Worries Inventory; VAS: Visual-Analog Scale.
Grassi et al.
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et al.40 and Clarke and Kissane41 for the diagnosis of
demoralization; these include affective symptoms of exis-
tential distress (i.e., hopelessness or loss of meaning and
purpose in life); cognitive attitudes of pessimism, help-
lessness, sense of being trapped, personal failure, or lack
of a worthwhile future; absence of drive or motivation to
cope differently; associated features of social alienation or
isolation; and perceived lack of support.
Likewise, the DCPR construct of demoralization,
characterized by “feelings of hopelessness, helplessness,
or giving up, and inability to cope with some pressing
problems,”8 has been shown to be only partly associated
with major depression, both in other medically ill patients9
and in cancer patients.42,43
In summary, hopelessness appears to be a signiﬁcant
psychological dimension that merits further and more de-
tailed research in oncology in order to better understand
the role of psychological factors in medical conditions44
and develop more speciﬁc interventions.
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